Endotoxin tolerance enhances interleukin-10 renal expression and decreases ischemia-reperfusion renal injury in rats

Shock

Volumn 25, Issue 4, 2006, Pages 384-388

  Godet, Cendrine ^a   Goujon, Jean Michel ^a   Petit, Isabelle ^a   Lecron, Jean Claude ^a   Hauet, Thierry ^a   Mauco, Gérard ^a   Carretier, Michel ^a   Robert, Rene ^a,b  

^a UNIVERSITÉ DE POITIERS   (France)

^b Service de Psychiatrie Psychol Med   (France)

Author keywords

IL 10; IL 6; Ischemia reperfusion; LPS tolerance; Renal; TNF

Indexed keywords

CREATININE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DISORDER; NEPHRECTOMY; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; INTERLEUKIN-10; KIDNEY; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 33646774723     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000209528.35743.54     Document Type: Article

References (35)

1. Wang M, Meng X, Tsai B, Wang JF, Turrentine M, Brown JW, Meldrum DR: Endotoxin tolerance (LPS-preconditioning) is associated with a down-regulation of proinflammatory monokine production. Preconditioning up-regulates the soluble TNF receptor I response to endotoxin. J Surg Res 121:20-24, 2004.
2. West MA, Heagy W: Endotoxin tolerance: a review. Crit Care Med 30:64-73, 2002.
3. Wang JH, Doyle M, Manning BJ, Blankson S, Wu QD, Power C, Cahill R, Redmond HP, Ackerman M, Reuter M, et al.: Cytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock. J Endotoxin Res 7:105-112, 2001.
4. Langdale LA, Kajikawa O, Frevert C, Liggitt HD: Sustained tolerance to lipopolysaccharide after liver ischemia-reperfusion injury. Shock 19:553-558, 2003.
5. Goujon JM, Hauet T, Menet E, Levillain P, Babin P, Carretier M: Histological evaluation of proximal tubule cell injury in isolated perfused pig kidneys exposed to cold ischemia. J Surg Res 82:228-233, 1999.
6. Fernandez ED, Siemers F, Flohe S, Nau M, Schade U: Effects of endotoxin tolerance on liver function after hepatic ischemia/reperfusion injury in the rat. Crit Care Med 30:165-170, 2002.
7. Brouckaert P, Spriggs DR, Demetri G: Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med 169:2257-2262, 1989.
8. Redl H, Schlag G, Ceska M: Interleukin-8 in baboon septicemia is partially dependent on tumor necrosis factor. J Infect Dis 167:1464-1466, 1993.
9. Kelly KJ: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14:1549-1558, 2003.
10. Kayama F, Yoshida T, Kodama Y, Matusi T, Mateson JM, Luster MI: Proinflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin. Cytokine 9:688-695, 1997.
11. Deng J, Kohda Y, Chiao H: Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 60:2118-2128, 2001.
12. Okada K, Fujita T, Minamoto K, Liao H, Naka Y, Pinsky DJ: Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J Biol Chem 275:21468-21476, 2000.
13. Engles RE, Huber TS, Zander DS, Hess PJ, Welborn MB, Moldawer LL, Seeger JM: Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J Surg Res 69:425-428, 1997.
14. Hayward R, Nossuli TO, Scalia R: Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur J Pharmacol 334:157-163, 1997.
15. Brown JM, Grosso MA, Terada LS: Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci U S A 86:2516-2520, 1989.
16. Colletti LM, Remick DG, Campbell DA: LPS pretreatment protects from hepatic ischemia/perfusion. J Surg Res 57:337-343, 1994.
17. Shimauchi H, Ogawa T, Okuda K, Kusumoto Y, Okada H: Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes. Infect Immun 67:2153-2159, 1999.
18. Ackermann M, Reuter M, Flohe S, Bahrami S, Redl H, Schade FU: Cytokine synthesis in the liver of endotoxin-tolerant and normal rats during hemorrhagic shock. J Endotoxin Res 7:105-112, 2001.
19. Heemann U, Szabo A, Hamar P, Müller V, Witzke O, Lutz J, Philipp T: Lipopolysaccharide pre-treatment protects from renal ischemia/reperfusion injury. Am J Pathol 156:287-293, 2000.
20. Robert R, Spitzer JA: Effects of females hormones (17beta-estradiol and progesterone) on nitric oxide production by alveolar macrophages in rats. Nitric oxide synthesis is down regulated in endotoxin tolerant rats. Nitric Oxide 1:10453-10462, 1997.
21. Akihino K, Akira H: Amelioration of post-ischemic renal injury by contralateral uninephrectomy: a role of endothelin-1. Nephrol Dial Transplant 16:1570-1576, 2001.
22. Garcia-Criado FJ, Eleno N, Santos-Benito F, Valdunciel JJ, Reverte M, Lozano-Sanchez FS, Ludena MD, Gomez-Alonso A, Lopez-Novoa JM: Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 66:982-990, 1998.
23. Shoskes DA, Parfrey NA, Halloran PF: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49:201-207, 1990.
24. Hourmant M: Le syndrome d'ischémie reperfusion rénale. Néphrologie 20:371-375, 1999.
25. Deamen M, Van de Ven M, Heineman E, Buurman W: Involvement of endogenous interleukin-10 and tumor necrosis factor-α in renal ischemia-reperfusion injury. Transplantation 67:792-800, 1999.
26. Sheppard BC, Fraker DL, Norton JA: Prevention and treatment of endotoxin and sepsis lethality with recombinant tumor necrosis factor. Surgery 106:156-160, 1989.
27. Engelmann H, Novick D, Wallach D: Two tumor necrosis factor-binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531-1536, 1990.
28. Fernandez ED, Flohe S, Siemers F, Nau M, Ackermann M, Ruwe M, Schade FU: Endotoxin tolerance protects against local hepatic ischemia/reperfusion injury in the rat. J Endotoxin Res 6:321-328, 2000.
29. De Waal Malefyt L, Abrams J, Benett B, Figdor CG, de Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
30. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550, 1993.
31. Koken T, Serteser M, Kahraman A, Akbulut G, Dilek ON: Which is more effective in the prevention of renal ischemia-reperfusion oxidative injury in the early period in mice: interleukin (IL)-10 or anti-IL-12? Clin Biochem 37:50-55, 2004.
32. De Vries JE: Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27:537-541, 1995.
33. Kühn R, Löhler J, Rennick D: Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993.
34. Ghosh S, May MJ, Kopp EB: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Anna Rev Immunol 16:225-260, 1998.
35. Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor κB. Hepatology 30:203-208, 1999.